Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer

Hiroyuki Okudaira, Naoto Shikano, Ryuichi Nishii, Tohru Miyagi, Mitsuyoshi Yoshimoto, Masato Kobayashi, Kazuyo Ohe, Takeo Nakanishi, Ikumi Tamai, Mikio Namiki and Keiichi Kawai
Journal of Nuclear Medicine May 2011, 52 (5) 822-829; DOI: https://doi.org/10.2967/jnumed.110.086074
Hiroyuki Okudaira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoto Shikano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryuichi Nishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Miyagi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuyoshi Yoshimoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Kobayashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuyo Ohe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeo Nakanishi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikumi Tamai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikio Namiki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiichi Kawai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Comparison of 14C-FACBC, 14C-Ala, 14C-Leu, and 14C-Met uptake by DU145 cells. Data are expressed as percentage of uptake in cells that were incubated without inhibitors. Uninhibited uptake of 14C-FACBC, 14C-Ala, 14C-Leu, and 14C-Met was 6,510.71, 3,086.29, 3,193.04, and 4,036.06 pmol/mg of protein, respectively. Each bar represents mean and SD (n = 3–6). *P < 0.05. **P < 0.01.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    mRNA expression levels of amino acid transporters in human prostate biopsy specimens (A) and DU145 cells (B) determined by qRT-PCR. Each bar represents mean and SD (n = 3). rRNA = ribosomal RNA.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Correlation between log ratio of amino acid transporters in human prostate biopsy specimens determined by cDNA microarray and qRT-PCR. **P < 0.01.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Effects of ASCT2 or SNAT2 knockdown, compared with control siRNA-transfected cells. (A) mRNA expression levels of amino acid transporters in siRNA-treated DU145 cells. (B) Uptake of 14C-FACBC, 14C-Ala, 14C-Leu, and 14C-Met by each siRNA-transfected DU145 cell. Each bar represents mean and SD (n = 6). **P < 0.01.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Intracellular distribution of 14C-FACBC (A) and 14C-Met (B) when DU145 cells were incubated with each tracer for 3 or 24 h. Each bar represents mean and SD (n = 3), except 14C-FACBC for 3 h, which represents mean (n = 2).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    List of Human Prostate Biopsy Specimens

    Patient no.Prostate-specific antigen (ng/mL)Gleason score
    Normal prostate
     13.6—
     25.1—
     39.0—
    Adenocarcinoma
     455.04 + 4 = 8
     596.04 + 4 = 8
     6227.84 + 4 = 8

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (5)
Journal of Nuclear Medicine
Vol. 52, Issue 5
May 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer
Hiroyuki Okudaira, Naoto Shikano, Ryuichi Nishii, Tohru Miyagi, Mitsuyoshi Yoshimoto, Masato Kobayashi, Kazuyo Ohe, Takeo Nakanishi, Ikumi Tamai, Mikio Namiki, Keiichi Kawai
Journal of Nuclear Medicine May 2011, 52 (5) 822-829; DOI: 10.2967/jnumed.110.086074

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer
Hiroyuki Okudaira, Naoto Shikano, Ryuichi Nishii, Tohru Miyagi, Mitsuyoshi Yoshimoto, Masato Kobayashi, Kazuyo Ohe, Takeo Nakanishi, Ikumi Tamai, Mikio Namiki, Keiichi Kawai
Journal of Nuclear Medicine May 2011, 52 (5) 822-829; DOI: 10.2967/jnumed.110.086074
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
  • Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
  • The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer
  • Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer
  • Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs
  • Anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease
  • Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents
  • Preparation and Characterization of L-[5-11C]-Glutamine for Metabolic Imaging of Tumors
  • PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine
  • Google Scholar

More in this TOC Section

  • 225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2–Expressing Breast Cancer
  • 212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
  • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
Show more Basic Science Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire